AXIM BIOTECHNOLOGIES, INC. Proceeds from Issuance or Sale of Equity
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Proceeds from Issuance or Sale of Equity of $129.27 thousand for the 8-month period ending 2021-12-31, per its 10-K/A filed 2022-04-19.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2022-04-19
- 2021-12-31: Proceeds from Issuance or Sale of Equity 8 month $129.27K.
| Period end | Proceeds from Issuance or Sale of Equity 8 month |
|---|---|
| 2021-12-31 | $129.27K 10-K/A · filed 2022-04-19 |